home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Kinnate Biopharma Inc. Reports Full Year 2021 Financial Results and Provides Operational Updates
Kinnate Biopharma Inc. Reports Full Year 2021 Financial Results and Provides Operational Updates
Post navigation
Previous Post
Previous
Blueprint Medicines’ AYVAKYT® (avapritinib) Receives European Commission Approval for the Treatment of Adults with Advanced Systemic Mastocytosis
Next Post
Next
Cullinan Oncology Announces Clinical and Regulatory Update for CLN-081 in NSCLC EGFR Exon 20 Patients